Get the Stockscreener App
12.17
1.08%
0.13
Lensar Inc stock is traded at $12.17, with a volume of 103.47K.
It is up +1.08% in the last 24 hours and down -5.95% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
See More
Previous Close:
$12.04
Open:
$12.09
24h Volume:
103.47K
Relative Volume:
1.08
Market Cap:
$145.25M
Revenue:
$42.16M
Net Income/Loss:
$-14.38M
P/E Ratio:
-6.7989
EPS:
-1.79
Net Cash Flow:
$-9.90M
1W Performance:
+0.16%
1M Performance:
-5.95%
6M Performance:
-13.01%
1Y Performance:
+174.97%
1-Day Range:
$11.95
$12.24
1-Week Range:
$11.60
$12.49
52-Week Range:
$3.8001
$17.31
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
12.17 | 147.39M | 42.16M | -14.38M | -9.90M | -1.79 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
How to build a custom watchlist for LENSAR Inc.2025 Year in Review & Scalable Portfolio Growth Ideas - Newser
Visual trend scoring systems applied to LENSAR Inc.July 2025 Retail & Fast Entry High Yield Tips - Newser
Is LENSAR Inc. a momentum stockJuly 2025 Retail & Low Risk Entry Point Tips - khodrobank.com
Can LENSAR Inc. be the next market leaderWeekly Market Report & Low Drawdown Momentum Trade Ideas - khodrobank.com
Will LENSAR Inc. stock go up soonDollar Strength & Real-Time Buy Signal Alerts - Newser
Is LENSAR Inc. stock poised for growth2025 Support & Resistance & Momentum Based Trading Signals - Newser
Using Bollinger Bands to evaluate LENSAR Inc.Weekly Investment Report & Verified Entry Point Signals - Newser
Is LENSAR Inc. meeting your algorithmic filter criteriaWeekly Trade Summary & AI Enhanced Trade Execution Alerts - Newser
What makes LENSAR Inc. stock price move sharplyWeekly Profit Report & Fast Exit and Entry Strategy Plans - Newser
Will LENSAR Inc. benefit from macro trendsPortfolio Risk Summary & Fast Entry Momentum Alerts - Newser
What are analysts’ price targets for LENSAR Inc.New Guidance & High Accuracy Swing Entry Alerts - khodrobank.com
Understanding LENSAR Inc.’s price movementTrade Performance Summary & Comprehensive Market Scan Reports - Newser
LENSAR reports inducement grants - Medical Buyer
Developing predictive dashboards with LENSAR Inc. dataJuly 2025 Analyst Calls & Real-Time Market Sentiment Reports - Newser
What is LENSAR Inc. s P E ratio telling usProfit Target & Safe Swing Trade Setups - khodrobank.com
Can LENSAR Inc. disrupt its industryJuly 2025 News Drivers & Momentum Based Trading Ideas - khodrobank.com
How to integrate LENSAR Inc. into portfolio analysis toolsJuly 2025 Institutional & Momentum Based Trading Ideas - Newser
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
LENSAR’s Strategic Use of Inducement Grants and Its Implications for Talent Retention and Long-Term Growth - AInvest
Lensar reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Medical Laser Company LENSAR Issues 660 Restricted Stock Units to Three New Non-Executive Hires - Stock Titan
What does recent volatility data suggest for LENSAR Inc.July 2025 Recap & Expert Approved Momentum Trade Ideas - Newser
Is now a turning point for LENSAR Inc.2025 Institutional Moves & Growth Focused Entry Point Reports - Newser
Can LENSAR Inc. navigate macro headwindsDip Buying & Expert Approved Momentum Ideas - khodrobank.com
Applying Wyckoff theory to LENSAR Inc. stockJuly 2025 Institutional & Long-Term Investment Growth Plans - Newser
Will LENSAR Inc. rebound enough to break evenJuly 2025 Weekly Recap & Accurate Buy Signal Notifications - Newser
What’s the recovery path for long term holders of LENSAR Inc.IPO Watch & Accurate Entry and Exit Point Alerts - Newser
Detecting support and resistance levels for LENSAR Inc.Gap Down & Safe Entry Point Alerts - Newser
How to recover losses in LENSAR Inc. stockJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - Newser
Short interest data insights for LENSAR Inc.July 2025 Earnings & Long-Term Safe Return Strategies - Newser
Lensar (LNSR) Q2 Revenue Rises 10% - AOL.com
Sector ETF performance correlation with LENSAR Inc.Buy Signal & Fast Exit/Entry Strategy Plans - Newser
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.38%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):